Top Biotechnology companies in Canada by EBITDA Margin

This ranking features the top 15 Biotechnology companies in Canada ranked by EBITDA Margin, averaging a EBITDA Margin of -4,279.00%, for February 06, 2025.
#
Name
EBITDA Margin
Reported Date
Stock Price
Change
Price (30 days) Country
1
53.21%
Dec. 31, 2023 USD 9.51 -0.80%

Canada

2
20.43%
Dec. 31, 2023 USD 2.96 1.10%

Canada

3
17.05%
March 31, 2024 USD 2.65 -1.93%

Canada

4
12.46%
Dec. 31, 2023 USD 4.00 3.39%

Canada

5
-12.06%
Nov. 30, 2023 USD 1.52 2.02%

Canada

6
-15.87%
Dec. 31, 2023 USD 2.85 2.89%

Canada

7
-35.92%
Dec. 31, 2023 USD 7.95 -0.62%

Canada

8
-158.79%
Dec. 31, 2023 USD 14.60 -0.95%

Canada

9
-223.48%
Dec. 31, 2023 USD 1.22 2.52%

Canada

10
-372.01%
Dec. 31, 2023 USD 6.23 -0.19%

Canada

11
-505.35%
Dec. 31, 2023 USD 3.17 -1.86%

Canada

12
-1,146.05%
Dec. 31, 2023 USD 0.15 -5.56%

Canada

13
-5,684.50%
Dec. 31, 2023 USD 1.97 -2.48%

Canada

14
-18,979.61%
Dec. 31, 2023 USD 2.34 -2.50%

Canada

15
-37,154.53%
March 31, 2024 USD 1.14 2.02%

Canada

Frequently Asked Questions
  • Which Biotechnology company in Canada has the highest EBITDA Margin ?

    The Biotechnology company in Canada with the highest EBITDA Margin is Cipher Pharmaceuticals Inc. (Toronto Stock Exchange: CPH.TO) at 53.21%.

  • Which Biotechnology company in Canada has the lowest EBITDA Margin ?

    The Biotechnology company in Canada with the lowest EBITDA Margin is Zentek Ltd. (TSXV: ZEN.V) at -37,154.53%.

SV Wall Street